Home

medzi to etický webb jordan 2017 ovarian cancer Amerika korále výložník

METTL3 promotes the initiation and metastasis of ovarian cancer by  inhibiting CCNG2 expression via promoting the maturation of  pri-microRNA-1246 | Cell Death Discovery
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246 | Cell Death Discovery

PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in  desensitization to carboplatin in patients with ovarian cancer
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

Frontiers | Tumor Microenvironment in Ovarian Cancer: Function and  Therapeutic Strategy
Frontiers | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy

Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary
Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary

Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer | ACS Medicinal  Chemistry Letters
Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer | ACS Medicinal Chemistry Letters

Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian  Cancer Carcinogenesis, Progression and Treatment
Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment

Epidemiology of epithelial ovarian cancer - ScienceDirect
Epidemiology of epithelial ovarian cancer - ScienceDirect

Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan -  2021 - International Journal of Cancer - Wiley Online Library
Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library

CIMB | Free Full-Text | Immunotherapeutic Approaches in Ovarian Cancer
CIMB | Free Full-Text | Immunotherapeutic Approaches in Ovarian Cancer

Frontiers | Ovarian cancer subtypes based on the regulatory genes of RNA  modifications: Novel prediction model of prognosis
Frontiers | Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis

IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active  Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs

Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A  SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley  Online Library
Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley Online Library

Validating genetic risk associations for ovarian cancer through the  international Ovarian Cancer Association Consortium | British Journal of  Cancer
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer

Medicina | Free Full-Text | Progression Free Survival, Overall Survival,  and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective  Analysis
Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis

IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation  and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to  Topotecan
IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan

Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer  and Upregulates its Expression of Ox40L and 4-1BBL
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL

Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer  Screening and Diagnostics: A Comprehensive Review
Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review

An epidemiologic risk prediction model for ovarian cancer in Europe: the  EPIC study | British Journal of Cancer
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer

Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target  Genes in Ovarian Cancer
Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer

Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer  Risk: A Meta-Analysis of Ten Epidemiological Studies
Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies

RNA epigenetic modifications in ovarian cancer: The changes, chances, and  challenges - Ye - WIREs RNA - Wiley Online Library
RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges - Ye - WIREs RNA - Wiley Online Library

Statin use and survival among women with ovarian cancer: an Australian  national data-linkage study | British Journal of Cancer
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer

The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A  review - ScienceDirect
The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review - ScienceDirect

Frontiers | Disease Burden and Attributable Risk Factors of Ovarian Cancer  From 1990 to 2017: Findings From the Global Burden of Disease Study 2017
Frontiers | Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017